Pharmaceutical companies are increasingly interested in digital therapeutics, which use data analytics--sometimes in combination with medications, to monitor patients and potentially improve disease outcomes and lower healthcare costs.
from Forbes Real Time https://www.forbes.com/sites/zinamoukheiber/2018/05/30/with-20-million-in-funding-propeller-health-partners-with-aptar-pharma-to-make-digital-medicines/
via IFTTT
No comments:
Post a Comment